Physician

Roneka Leantrice Ravenell, MD

According to 2025 Medicare claims, Roneka Ravenell, MD (NPI: 1972682334) practices rheumatology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Clark, IN. This provider's primary affiliated billing organization is LAKE CUMBERLAND RHEUMATOLOGY, PLLC (NPI: 1619117058; TIN: 264240766) and primary practice location at 47150-9562.

Ravenell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 349 traditional Medicare patients, billed 151,602 HCPCS/CPT codes, and received $1,679,699 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 904 prescription claims across 190 beneficiaries totaling $691,411 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 163 records totaling $2,890. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,744 to $1,679,699. Similarly, Part D prescription costs have risen steadily, from $439,845 to $691,411. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$864K$1.7M2015 Medicare payment: $4,744 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $128,255 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $561,103 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,728,870 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,679,699 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154589$4,744
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20211388,728$128,255
202225237,719$561,103
2023362136,147$1,728,870
2024349151,602$1,679,699

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$495K$990K2015 Drug cost: $439,845 (USD; Tot_Drug_Cst)2016 Drug cost: $131,890 (USD; Tot_Drug_Cst)2017 Drug cost: $4,381 (USD; Tot_Drug_Cst)2018 Drug cost: $48,303 (USD; Tot_Drug_Cst)2019 Drug cost: $7,549 (USD; Tot_Drug_Cst)2020 Drug cost: $230,145 (USD; Tot_Drug_Cst)2021 Drug cost: $662,801 (USD; Tot_Drug_Cst)2022 Drug cost: $811,068 (USD; Tot_Drug_Cst)2023 Drug cost: $990,370 (USD; Tot_Drug_Cst)2024 Drug cost: $691,411 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201552500$439,845
201630135$131,890
2017N/R34$4,381
2018N/R29$48,303
20192134$7,549
2020106355$230,145
2021148724$662,801
2022176842$811,068
2023200853$990,370
2024190904$691,411

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less61153$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more137258$81
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less80328$45
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's118204$12
96372Injection of drug or substance under skin or into muscle115456$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept28784$198,535
Humira(Cf) PenAdalimumab11308$77,012
Xeljanz XrTofacitinib Citrate12360$71,490
ProliaDenosumab152,700$26,522
Hydroxychloroquine SulfateHydroxychloroquine Sulfate18511,081$5,022

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.163$2,890Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Roneka Leantrice Ravenell, MD?

Tedicare shows public-source Medicare data for Roneka Leantrice Ravenell, MD (NPI 1972682334), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Roneka Leantrice Ravenell, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Roneka Leantrice Ravenell, MD?

Roneka Leantrice Ravenell, MD is linked to LAKE CUMBERLAND RHEUMATOLOGY, PLLC (billing NPI 1619117058) in the available physician profile data.

Does Roneka Leantrice Ravenell, MD have Open Payments data?

Roneka Leantrice Ravenell, MD has 163 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.